The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*Yan Zhao, J Zhang, Liming Wu et al.|British Journal of Dermatology|2021Cited by 73
A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosusQianwen Li, Qianjin Lu, Haijing Wu et al.|Journal of Autoimmunity|2018Cited by 54
Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trialYan Zhao, Bo Chen, Fuqiu Li et al.|Chinese Medical Journal|2023Cited by 40
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trialYan Zhao, Jianzhong Zhang, Litao Zhang et al.|Allergy|2024Cited by 30
Efficacy and safety of SHR8554 on postoperative pain in subjects with moderate to severe acute pain following orthopedic surgery: A multicenter, randomized, double-blind, dose-explored, active-controlled, phase II/III clinical trialYanhua Zhao, Xiyao Gu, Zhisheng Lu et al.|Pharmacological Research|2025Cited by 16